Samsung Biologics Co.,Ltd. (KRX: 207940)
South Korea
· Delayed Price · Currency is KRW 937,000
-20,000 (-2.09%)
Nov 15, 2024, 3:30 PM KST
Samsung Biologics Co.,Ltd. Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Nov '24 Nov 14, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Market Capitalization | 65,195,384 | 54,092,240 | 58,433,854 | 59,746,995 | 54,652,290 | 28,649,445 | Upgrade
|
| Market Cap Growth | -2.28% | -7.43% | -2.20% | 9.32% | 90.76% | 12.03% | Upgrade
|
| Enterprise Value | 65,308,340 | 54,470,492 | 57,778,382 | 59,669,232 | 54,358,190 | 28,694,172 | Upgrade
|
| Last Close Price | 916000.00 | 760000.00 | 821000.00 | 893509.47 | 817318.74 | 428449.17 | Upgrade
|
| PE Ratio | 63.39 | 63.07 | 71.82 | 150.20 | 224.41 | 139.71 | Upgrade
|
| Forward PE | 59.53 | 60.08 | 82.37 | 112.20 | 230.61 | - | Upgrade
|
| PS Ratio | 15.48 | 14.64 | 19.47 | 38.10 | 46.92 | 40.83 | Upgrade
|
| PB Ratio | 6.31 | 5.50 | 6.50 | 11.97 | 11.88 | 6.58 | Upgrade
|
| P/TBV Ratio | 7.26 | 8.23 | 10.14 | 12.05 | 11.94 | 6.61 | Upgrade
|
| P/FCF Ratio | 61.26 | 80.60 | - | 1235.91 | 875.48 | - | Upgrade
|
| P/OCF Ratio | 31.29 | 32.46 | 61.31 | 131.43 | 270.44 | 2821.60 | Upgrade
|
| PEG Ratio | 3.19 | 3.45 | 8.16 | 3.45 | 7.19 | - | Upgrade
|
| EV/Sales Ratio | 15.51 | 14.74 | 19.25 | 38.05 | 46.67 | 40.90 | Upgrade
|
| EV/EBITDA Ratio | 34.45 | 33.97 | 44.72 | 85.35 | 124.54 | 127.74 | Upgrade
|
| EV/EBIT Ratio | 49.33 | 48.91 | 58.74 | 111.05 | 185.66 | 312.77 | Upgrade
|
| EV/FCF Ratio | 61.37 | 81.16 | - | 1234.30 | 870.77 | - | Upgrade
|
| Debt / Equity Ratio | 0.16 | 0.19 | 0.28 | 0.26 | 0.17 | 0.15 | Upgrade
|
| Debt / EBITDA Ratio | 0.89 | 1.19 | 1.95 | 1.85 | 1.80 | 2.91 | Upgrade
|
| Debt / FCF Ratio | 1.58 | 2.84 | - | 26.74 | 12.57 | - | Upgrade
|
| Asset Turnover | 0.26 | 0.23 | 0.24 | 0.22 | 0.19 | 0.12 | Upgrade
|
| Inventory Turnover | 0.80 | 0.76 | 0.91 | 1.02 | 1.37 | 1.35 | Upgrade
|
| Quick Ratio | 0.39 | 0.49 | 0.76 | 1.24 | 1.45 | 1.00 | Upgrade
|
| Current Ratio | 1.35 | 1.33 | 1.54 | 2.55 | 2.97 | 1.96 | Upgrade
|
| Return on Equity (ROE) | 10.47% | 9.12% | 11.42% | 8.21% | 5.38% | 4.77% | Upgrade
|
| Return on Assets (ROA) | 5.17% | 4.27% | 5.01% | 4.67% | 2.97% | 0.96% | Upgrade
|
| Return on Capital (ROIC) | 6.99% | 5.99% | 6.91% | 5.76% | 3.52% | 1.14% | Upgrade
|
| Earnings Yield | 1.58% | 1.59% | 1.37% | 0.66% | 0.44% | 0.71% | Upgrade
|
| FCF Yield | 1.63% | 1.24% | -0.01% | 0.08% | 0.11% | -0.64% | Upgrade
|
| Buyback Yield / Dilution | 0.01% | -1.95% | -5.51% | - | - | - | Upgrade
|
| Total Shareholder Return | 0.01% | -1.95% | -5.51% | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.